U.S. Surgical Sutures Market Revenue & Forecast Analysis, 2026-2035
The U.S. surgical sutures market was evaluated at USD 2,019.11 million in 2025 and is projected to grow at a CAGR of 5.0% from USD 2,106.94 million in 2026 to USD 3,268.41 million in 2035. The robust market expansion is mainly influenced by the escalating volume of surgical operations, increasing incidence of chronic conditions necessitating surgical treatment, and heightened need for efficient wound closure products. Additionally, progress in absorbable and antimicrobial-coated sutures, greater utilization of minimally invasive surgical techniques, and growing healthcare spending are driving the growth of the U.S. surgical sutures market.
Market Overview
The Centers for Disease Control and Prevention reports that more than 48 million surgical procedures are conducted yearly in the United States, highlighting ongoing demand for surgical sutures utilized in closing wounds and approximating tissues.
The U.S. surgical sutures market has expanded consistently over time, driven by the increasing number of surgical operations, higher rates of chronic illnesses, and a rising need for efficient wound closure solutions. Improvements in absorbable stitches, antimicrobial-coated stitches, and minimally invasive procedures have enhanced patient results and lowered the chance of postoperative complications. For instance, in 2024, Johnson & Johnson MedTech (Ethicon) kept broadening its advanced wound closure range, addressing the increasing need for high-quality surgical sutures in U.S. healthcare institutions.
The U.S. surgical sutures market is projected to experience significant growth throughout the forecast period due to the rising number of orthopedic, cardiovascular, and general surgical operations, as well as ongoing advancements in suture materials and wound care technologies. The increased demand for sutures that are absorbable and resistant to infections is also driving market growth. For instance, by 2035, it is anticipated that U.S. hospitals and surgical centers will significantly increase their use of next-generation antimicrobial and bioactive sutures created by companies like Medtronic plc, motivated by the desire to minimize surgical site infections and enhance wound healing results.
U.S. Surgical Sutures Market Overview
Base Year Market Size (2025): USD 2,019.11 Million
CAGR: 5.0%
Forecast Year Market Size (2035): USD 3,268.41 Million
Major Players:
B. Braun SE
Johnson & Johnson MedTech (Ethicon)
Medtronic plc
Smith & Nephew plc
Teleflex Incorporated
U.S. Surgical Sutures Market Trends
The U.S. surgical sutures market is progressing consistently due to innovations in wound closure techniques, rising surgical procedures, and a heightened focus on minimizing postoperative issues.
The growing use of absorbable sutures is enhancing patient results by removing the necessity for suture removal and facilitating quicker healing processes.
The increasing need for antimicrobial-coated sutures is aiding in lowering the incidence of surgical site infections (SSIs), especially in complex and high-risk surgeries.
Improvements in bioactive and synthetic suture materials are increasing tensile strength, compatibility with tissues, and overall effectiveness in wound healing.
The increasing prevalence of robotic-assisted and minimally invasive surgeries is boosting the need for specialized sutures aimed at precise wound closure and enhanced surgical effectiveness.
Moreover, healthcare providers are placing greater emphasis on advanced wound care solutions that promote faster healing, shorter hospital stays, and improved patient results.
Collectively, these technological innovations and the increasing emphasis on surgical safety and wound recovery are anticipated to propel the sustained expansion of the U.S. surgical sutures market.
U.S. Surgical Sutures Market Analysis
By Product Type
Absorbable sutures dominate the U.S. surgical sutures market due to their convenience, reduced follow-up requirements, and widespread use across surgical specialties
Based on the product type, the U.S. surgical sutures market is categorized into absorbable sutures and non-absorbable sutures. The absorbable sutures segment leads the market with the highest market share of 61.46% in 2025.
By Structure
Multifilament sutures dominate the U.S. surgical sutures market owing to their superior knot security, flexibility, and ease of handling during surgical procedures
Based on the structure, the U.S. surgical sutures market is categorized into monofilament and multifilament sutures. The multifilament segment leads the market with the highest market share in 2025.
By Material Type
Synthetic sutures dominate the U.S. surgical sutures market due to their superior strength, predictable absorption profiles, and lower risk of tissue reaction
Based on the material type, the U.S. surgical sutures market is categorized into natural and synthetic sutures. The synthetic segment dominates the market with the highest market share in 2025.
By Application
General surgery dominates the U.S. surgical sutures market due to the high volume of procedures requiring reliable and effective wound closure solutions.
Based on the application, the U.S. surgical sutures market is categorized into general surgery, cardiovascular surgery, orthopedic surgery, gynecology & obstetrics, ophthalmic surgery, and others. The general surgery segment leads the market with the highest market share in 2025.
Key Companies Profiled
The U.S. surgical sutures market features a competitive environment with established medical device and wound closure firms competing through advanced suture materials, antimicrobial innovations, and creative surgical solutions. Prominent firms such as Johnson & Johnson MedTech (Ethicon), Medtronic plc, B. Braun SE, Smith & Nephew plc, and Teleflex Incorporated command a notable portion of the market, backed by vast product ranges, robust distribution channels, and ongoing investments in surgical advancements.
The market is intensely competitive, with firms concentrating on absorbable sutures, antimicrobial-coated wound closure items, synthetic suture materials, and innovative tissue repair technologies to enhance their market standing. The rising demand for minimally invasive surgeries, increasing volumes of surgical procedures, and heightened focus on minimizing surgical site infections are intensifying competition among hospitals and ambulatory surgical centers. For instance, in 2024, Johnson & Johnson MedTech (Ethicon) further broadened its portfolio of wound closure and surgical technologies, strengthening the competitive environment of the U.S. surgical sutures market.
U.S. Surgical Sutures Market Companies:
Some of the key companies operating in the U.S. Surgical Sutures Market include:
Advanced Medical Solutions Group plc
B. Braun SE
DemeTECH Corporation
Healthium Medtech Limited
Integra LifeSciences Holdings Corporation
Johnson & Johnson MedTech (Ethicon)
Medtronic plc
Meril Life Sciences Pvt. Ltd.
Peters Surgical SAS
Riverpoint Medical LLC
Samyang Biopharmaceuticals Corporation
Smith & Nephew plc
Surgical Specialties Corporation
Teleflex Incorporated
W. L. Gore & Associates, Inc.
Market Segmentation
This study provides revenue growth and emerging trends across U.S. from 2021 to 2035, segmenting the U.S. surgical sutures market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Absorbable Sutures
Non-Absorbable Sutures
Structure (Revenue in USD Million, 2021 - 2035)
Monofilament
Multifilament
Material Type (Revenue in USD Million, 2021 – 2035)
Natural
Synthetic
Application (Revenue in USD Million, 2021 – 2035)
General Surgery
Cardiovascular Surgery
Orthopedic Surgery
Gynecology & Obstetrics
Ophthalmic Surgery
Others
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Consumer Behaviour Analysis
3.5. Value Chain Analysis
3.6. Technology Roadmap
3.7. Porters Analysis
3.8. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Absorbable Sutures
4.2. Non-Absorbable Sutures
5. Market Estimates and Forecasts, By Structure, 2021 – 2035 (USD Mn)
5.1. Monofilament
5.2. Multifilament
6. Market Estimates and Forecasts, By Material Type, 2021 – 2035 (USD Mn)
6.1. Natural
6.2. Synthetic
7. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)
7.1. General Surgery
7.2. Cardiovascular Surgery
7.3. Orthopedic Surgery
7.4. Gynecology & Obstetrics
7.5. Ophthalmic Surgery
7.6. Others
8. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
8.1.1. U.S.
8.1.1.1. U.S. Surgical Sutures Market Estimates and Forecasts to 2035 (USD Mn)
8.1.1.2. Market Dynamics
8.1.1.3. Competitive Landscape
8.1.1.4. Regulatory Framework
8.1.1.5. Reimbursement Scenario
9. Competitive Landscape
9.1. Company Market Share Analysis, 2025
9.2. Company Tier Structure
9.3. List of Major Suppliers, By Key Countries
9.4. Key Company Positioning Analysis
9.5. Company Profile
9.5.1. Advanced Medical Solutions Group plc
9.5.2. B. Braun SE
9.5.3. DemeTECH Corporation
9.5.4. Healthium Medtech Limited
9.5.5. Integra LifeSciences Holdings Corporation
9.5.6. Johnson & Johnson MedTech (Ethicon)
9.5.7. Medtronic plc
9.5.8. Meril Life Sciences Pvt. Ltd.
9.5.9. Peters Surgical SAS
9.5.10. Riverpoint Medical LLC
9.5.11. Samyang Biopharmaceuticals Corporation
9.5.12. Smith & Nephew plc
9.5.13. Surgical Specialties Corporation
9.5.14. Teleflex Incorporated
9.5.15. W. L. Gore & Associates, Inc.
10. Analyst Perspective
11. Related Reports
Related Research
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.